NACC1 and melanoma: In this study, we uncovered a new molecular mechanism by which NAC1 regulates NF-κB signaling, and demonstrate that the combinatorial inhibition of NAC1 and the NF-κB pathway can synergistically inhibit melanoma both in cultured cells and xenograft tumors.